Sphera Funds Management »

Jasper Therapeuritc shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $15M 505k 29.36

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sanofi Sponsored Adr (SNY)
Nice Sponsored Adr (NICE)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Syndax Pharmaceuticals (SNDX)
Biogen Idec (BIIB)
Jasper Therapeutics Com New (JSPR)
IsoRay (CATX)
Ultragenyx Pharmaceutical (RARE)
Merck & Co (MRK)
Kura Oncology (KURA)
Astrazeneca Sponsored Adr (AZN)
Sentinelone Cl A (S)

View all positions for Sphera Funds Management

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Carlyle
Avidity Partners Management
Franklin Resources
Vanguard Group
Samsara BioCapital
Sphera Funds Management
Octagon Capital Advisors
Kingdon Capital Management
Opaleye Management
Dr. Jeffrey R. Jay, M.D.
Rock Springs Capital Management
Woodline Partners
Boxer Capital

View all funds holding Jasper Therapeuritc